{
    "clinical_study": {
        "@rank": "55332", 
        "arm_group": [
            {
                "arm_group_label": "Active rTMS treatment", 
                "arm_group_type": "Experimental", 
                "description": "Active Cervel Neurotech Multi-Coil Transcranial Magnetic Stimulator"
            }, 
            {
                "arm_group_label": "Sham rTMS treatment", 
                "arm_group_type": "Sham Comparator", 
                "description": "Inactive Cervel Neurotech Multi-Coil Transcranial Magnetic Stimulator"
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to determine whether the Cervel Neurotech rTMS device is safe\n      and effective in the treatment of depression in people who do not get better with\n      antidepressant medications or cannot take antidepressant medications."
        }, 
        "brief_title": "A Clinical Trial for the Treatment of Depression With Repetitive Transcranial Magnetic Stimulation (rTMS)", 
        "condition": "Depressive Disorder, Major", 
        "condition_browse": {
            "mesh_term": [
                "Depression", 
                "Depressive Disorder", 
                "Depressive Disorder, Major"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Current major depressive disorder (MDD)\n\n          -  Resistance or intolerance to antidepressant medication in the current depressive\n             episode, or intolerance to antidepressant medication in a past depressive episode\n\n          -  On a stable psychotropic regimen prior to screening and be willing to maintain the\n             current regimen and dosing for the duration of the study\n\n          -  Weight less than 350 pounds\n\n        Exclusion Criteria:\n\n          -  Current major depressive disorder episode of more than three years\n\n          -  Seizure disorder\n\n          -  History of brain injury, stroke or active central nervous system disease\n\n          -  Cardiac pacemaker, implanted device (deep brain stimulation) or metal in the brain,\n             cervical spinal cord, or upper thoracic spinal cord unless deemed MRI-safe\n\n          -  Active suicidal intent or plan\n\n          -  Other significant psychiatric disorder\n\n          -  Alcohol or substance dependence or abuse\n\n          -  Prior treatment with transcranial magnetic stimulation\n\n          -  Have failed to clinically remit to an adequate trial of electroconvulsive therapy or\n             vagus nerve stimulation\n\n          -  If female, pregnant or lactating or planning to become pregnant within the next three\n             months"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "70 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "80", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "July 22, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01909232", 
            "org_study_id": "CN-CFS-TRMD-2"
        }, 
        "intervention": [
            {
                "arm_group_label": "Active rTMS treatment", 
                "description": "The Cervel Neurotech multi-coil transcranial magnetic stimulator is an investigational repetitive transcranial stimulation (rTMS) device.  In the active group, magnetic power output will be delivered to the subject through the coils.", 
                "intervention_name": "Active Cervel Neurotech Multi-Coil Transcranial Magnetic Stimulator", 
                "intervention_type": "Device"
            }, 
            {
                "arm_group_label": "Sham rTMS treatment", 
                "description": "The Cervel Neurotech multi-coil transcranial magnetic stimulator is an investigational repetitive transcranial stimulation (rTMS) device.  In the inactive group, no magnetic power output will be delivered to the subject through the coils.", 
                "intervention_name": "Inactive Cervel Neurotech Multi-Coil Transcranial Magnetic Stimulator", 
                "intervention_type": "Device"
            }
        ], 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "keyword": [
            "Depression", 
            "Depressive Disorder", 
            "Major depression", 
            "Major depressive disorder", 
            "MDD", 
            "Treatment resistant depression", 
            "Treatment intolerant depression", 
            "TRMD", 
            "TIMD", 
            "Transcranial Magnetic Stimulation", 
            "TMS"
        ], 
        "lastchanged_date": "May 28, 2014", 
        "link": [
            {
                "description": "Study Website", 
                "url": "http://www.TheDepressionTrial.com?prsid=53&praid=1&prtid=1"
            }, 
            {
                "description": "Sponsor Website", 
                "url": "http://www.cervel.com"
            }
        ], 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Atlanta", 
                        "country": "United States", 
                        "state": "Georgia", 
                        "zip": "30306"
                    }, 
                    "name": "Emory University"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Baltimore", 
                        "country": "United States", 
                        "state": "Maryland", 
                        "zip": "21285"
                    }, 
                    "name": "Sheppard-Pratt Health System"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Lebanon", 
                        "country": "United States", 
                        "state": "New Hampshire", 
                        "zip": "03756"
                    }, 
                    "name": "Dartmouth-Hitchcock Medical Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Portland", 
                        "country": "United States", 
                        "state": "Oregon", 
                        "zip": "97227"
                    }, 
                    "name": "Kaiser Permanente Center for Health Research"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Providence", 
                        "country": "United States", 
                        "state": "Rhode Island", 
                        "zip": "02906"
                    }, 
                    "name": "Butler Hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Salt Lake City", 
                        "country": "United States", 
                        "state": "Utah", 
                        "zip": "84106"
                    }, 
                    "name": "CRI Lifetree"
                }
            }
        ], 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "official_title": "A Prospective, Double-Blind, Randomized, Parallel-Group, Sham-Controlled Feasibility Trial of Multi-Coil Repetitive Transcranial Magnetic Stimulation (rTMS) for the Treatment of Major Depressive Disorder", 
        "overall_official": {
            "affiliation": "Cervel Neurotech", 
            "last_name": "Beth Stannard, BS, CCRP, CCRC", 
            "role": "Study Director"
        }, 
        "overall_status": "Active, not recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "July 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Measured by the 24-item Hamilton Rating Scale for Depression", 
            "measure": "Change in depression severity", 
            "safety_issue": "No", 
            "time_frame": "Baseline to four weeks (the conclusion of rTMS treatment)"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01909232"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "Measured by the 24-item Hamilton Rating Scale for Depression", 
                "measure": "Change in depression severity", 
                "safety_issue": "No", 
                "time_frame": "Baseline to eight weeks (four weeks after the conclusion of rTMS treatment)"
            }, 
            {
                "description": "Defined as greater than or equal to 50% decrease in the 24-item Hamilton Rating Scale for Depression score", 
                "measure": "Clinically significant response", 
                "safety_issue": "No", 
                "time_frame": "Baseline to four weeks (the conclusion of rTMS treatment)"
            }, 
            {
                "description": "Defined as greater than or equal to 50% decrease in the 24-item Hamilton Rating Scale for Depression score", 
                "measure": "Clinically significant response", 
                "safety_issue": "No", 
                "time_frame": "Baseline to eight weeks (four weeks after the conclusion of rTMS treatment)"
            }, 
            {
                "description": "Defined as 24-item Hamilton Rating Scale for Depression score less than or equal to 10", 
                "measure": "Remission from depression", 
                "safety_issue": "No", 
                "time_frame": "Baseline to four weeks (the conclusion of rTMS treatment)"
            }, 
            {
                "description": "Defined as 24-item Hamilton Rating Scale for Depression score less than or equal to 10", 
                "measure": "Remission from depression", 
                "safety_issue": "No", 
                "time_frame": "Baseline to eight weeks (four weeks after the conclusion of rTMS treatment)"
            }, 
            {
                "description": "Measured by the Quality of Life Enjoyment and Satisfaction Questionnaire Short Form", 
                "measure": "Change in quality of life", 
                "safety_issue": "No", 
                "time_frame": "Baseline to four weeks (the conclusion of rTMS treatment)"
            }, 
            {
                "description": "Measured by the Quality of Life Enjoyment and Satisfaction Questionnaire Short Form", 
                "measure": "Change in quality of life", 
                "safety_issue": "No", 
                "time_frame": "Baseline to eight weeks (four weeks after the conclusion of rTMS treatment)"
            }, 
            {
                "measure": "Incidence of treatment-emergent adverse events and serious adverse events", 
                "safety_issue": "Yes", 
                "time_frame": "Baseline to eight weeks (four weeks after the conclusion of rTMS treatment)"
            }
        ], 
        "source": "Cervel Neurotech, Inc.", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Cervel Neurotech, Inc.", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "July 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "May 2014"
    }
}